Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
65.69
-2.33 (-3.43%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Moderna Inc
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma Patients
June 03, 2024
Moderna and Merck's Phase 2b study results for mRNA-4157 combined with Keytruda, showing improvements in recurrence-free and distant metastasis-free survival for high-risk melanoma patients. Phase 3...
Via
Benzinga
Breaking Down Moderna: 7 Analysts Share Their Views
June 03, 2024
Via
Benzinga
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage
June 03, 2024
Via
ACCESSWIRE
Is Moderna Stock a Buy Now That It's a 2-Product Company?
June 03, 2024
The Food and Drug Administration recently approved a new vaccine from Moderna, but the stock dipped in response.
Via
The Motley Fool
Moderna Investors Just Got Some Bullish News
June 03, 2024
This news could be worth billions...
Via
The Motley Fool
Moderna Receives U.S. FDA Approval for RSV Vaccine mRESVIA(R)
May 31, 2024
Via
ACCESSWIRE
Why Moderna Stock Is Sinking This Week
May 30, 2024
Moderna's sell-off this week is for the birds.
Via
The Motley Fool
Moderna's Options Frenzy: What You Need to Know
May 29, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
May 31, 2024
Via
Benzinga
Moderna Scores FDA Approval For Its Second Product - Respiratory Syncytial Virus Vaccine
May 31, 2024
FDA approves Moderna's mRESVIA (mRNA-1345), an mRNA vaccine for RSV, for adults 60+. The second approved mRNA product from Moderna.
Via
Benzinga
Exposures
Product Safety
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
May 31, 2024
Moderna's RSV vaccine will launch a year behind Pfizer and GSK, but it could become the market leader over the next five years.
Via
Investor's Business Daily
Exposures
Product Safety
3 Sorry Biotech Stocks to Sell in May While You Still Can
May 31, 2024
Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell.
Via
InvestorPlace
Dyadic International Inc. (DYAI): Bird Flu Vaccine Development Amid Rising Pandemic Concerns
May 30, 2024
Via
AB Newswire
Exposures
COVID-19
Moderna Pops After Confirming The U.S. Government Could Back Its Bird Flu Vaccine
May 30, 2024
The company expects to have data soon from its Phase 1 and Phase 2 study of a bird flu vaccine.
Via
Investor's Business Daily
3 Nasdaq Stocks to Dump as They Near Peak Performance
May 30, 2024
Moderna, Constellation Energy and CrowdStrike are three Nasdaq stocks to sell, each offering unique exit points in a peaking market.
Via
InvestorPlace
Cathie Wood-LedArk Invest Cuts Robinhood Holdings Amid Bitcoin Dip, Keeps Selling Moderna Stock — Buys Palantir And AMD Shares
May 29, 2024
On Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades involving Robinhood Markets Inc (NASDAQ:HOOD), Moderna Inc (NASDAQ:MRNA), Palantir
Via
Benzinga
VIX Rises 8%, Treasury Yields Jump, Dow Plunges: Why Is Wall Street Wobbling Thursday?
May 29, 2024
Wall Street opens with red showing as investors worry about interest rates. Volatility and Treasury yields spike. Traders expect 1-2 rate cuts.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
3 Sorry Pharma Stocks to Sell in May While You Still Can
May 29, 2024
Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks.
Via
InvestorPlace
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.
Via
InvestorPlace
Exposures
Product Safety
Cathie Wood's Ark Invest Scoops Up Shares Of AMD And Palantir — Dumps Moderna Stock Worth $4.4M
May 28, 2024
Via
Benzinga
What's Going On With Moderna Stock Today?
May 28, 2024
Moderna Inc. (NASDAQ: MRNA) shares are trading lower Tuesday. The stock may be pulling back after gaining on bird flu concerns last week and predictions for a slight rise in COVID-19 cases.
Via
Benzinga
Exposures
COVID-19
US Stocks Waver, Nvidia Lifts Chipmakers, GameStop Spikes, Moderna Tumbles: What's Driving Markets Tuesday?
May 28, 2024
Wall Street resumed trading after the Memorial Day holiday with a familiar trend, as major chipmaker stocks significantly outperformed the broader market.
Via
Benzinga
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 28, 2024
Via
Benzinga
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock,
May 28, 2024
Jim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported better-than-expected first-quarter financial results.
Via
Benzinga
Moderna Was Among The Best Performing Large-Cap Stocks Last Week (May 20-May 26, 2024): Are They In Your Portfolio?
May 26, 2024
Top-performing stocks last week were FSLR, MRNA, ELF, NVDA, IP, ADI, FLEX, LOGI, BNTX, and MNDY, boosted by positive news and analyst targets.
Via
Benzinga
Should You Buy This Stock After a Regulatory Setback?
May 26, 2024
It's not uncommon for companies to face regulatory setbacks -- and It's not the end of the world.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
May 24, 2024
Via
Benzinga
Why Vaccine Stocks Rallied This Week
May 24, 2024
A bird flu outbreak could spur demand for vaccines from these key players, but is it likely?
Via
The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
May 23, 2024
Via
Benzinga
The Moderna News That Has MRNA Stock Price Surging: 3 Key Catalysts
May 23, 2024
MRNA stock has climbed more than 20% in just the past five trading sessions. What's behind Moderna's recent rally?
Via
InvestorPlace
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.